Tang Capital Management as of March 31, 2016
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 15 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Heron Therapeutics (HRTX) | 44.9 | $99M | 5.2M | 18.99 | |
| La Jolla Pharmaceuticl Com Par | 29.1 | $64M | 3.1M | 20.91 | |
| Opko Health Inc note 3.0% 2/1/33 | 9.9 | $22M | 14M | 1.56 | |
| BioMarin Pharmaceutical (BMRN) | 3.4 | $7.4M | 90k | 82.48 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 2.4 | $5.3M | 3.5M | 1.50 | |
| Sarepta Therapeutics (SRPT) | 2.2 | $4.9M | 250k | 19.52 | |
| Alibaba Group Holding (BABA) | 2.2 | $4.7M | 60k | 79.03 | |
| Opko Health (OPK) | 1.7 | $3.6M | 350k | 10.39 | |
| Nektar Therapeutics (NKTR) | 1.6 | $3.6M | 260k | 13.75 | |
| Infinity Pharmaceuticals (INFIQ) | 1.1 | $2.4M | 460k | 5.27 | |
| BioCryst Pharmaceuticals (BCRX) | 0.6 | $1.2M | 430k | 2.83 | |
| Lipocine | 0.5 | $1.0M | 100k | 10.15 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.3 | $749k | 190k | 3.94 | |
| Ignyta | 0.1 | $271k | 40k | 6.78 | |
| Celldex Therapeutics | 0.1 | $189k | 50k | 3.78 |
